Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.390
-0.070 (-4.79%)
At close: May 15, 2026, 4:00 PM EDT
1.419
+0.029 (2.12%)
After-hours: May 15, 2026, 7:58 PM EDT
Ocugen Market Cap
Ocugen has a market cap or net worth of $470.54 million as of May 15, 2026. Its market cap has increased by 118.35% in one year.
Market Cap
470.54M
Enterprise Value
471.98M
1-Year Change
118.35%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since December 3, 2014, Ocugen's market cap has increased from $126.80M to $470.54M, an increase of 271.09%. That is a compound annual growth rate of 12.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 470.50M | 11.60% |
| Dec 31, 2025 | 421.60M | 79.79% |
| Dec 31, 2024 | 234.50M | 58.98% |
| Dec 29, 2023 | 147.50M | -48.17% |
| Dec 30, 2022 | 284.60M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.67% |
| Dec 31, 2020 | 296.50M | 3,472.29% |
| Dec 31, 2019 | 8.30M | 50.91% |
| Dec 31, 2018 | 5.50M | -88.84% |
| Dec 29, 2017 | 49.30M | 85.34% |
| Dec 30, 2016 | 26.60M | -42.80% |
| Dec 31, 2015 | 46.50M | -60.86% |
| Dec 31, 2014 | 118.80M | -6.31% |
| Dec 3, 2014 | 126.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Upstream Bio | 494.68M |
| 4D Molecular Therapeutics | 478.33M |
| Avalo Therapeutics | 473.91M |
| Shattuck Labs | 473.14M |
| Neurogene | 471.21M |
| Assembly Biosciences | 455.32M |
| Ovid Therapeutics | 455.09M |
| Prelude Therapeutics | 450.59M |